Clinical Research Site
Cromwell, Connecticut 06416
3 studies enrolling now · 6 studies all time
What they study most
Agitation in Patients With Dementia of the Alzheimer's Type, Binge-Eating Disorder, Depression, Fibromyalgia, Major Depressive Disorder, Treatment Resistant Depression
Studies at this site
- Elucidating TAAR-1, Dopamine, and Norepinephrine in Binge Eating Disorder Using Solriamfetol — Recruiting now
- Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design — Recruiting now
- Progressing TAAR-1, Dopamine, and Norepinephrine in Depression Using Solriamfetol — Completed
- Open-Label Safety Study of Solriamfetol in Subjects With Binge Eating Disorder — Enrolling by invitation
- Efficacy, Safety and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type — Completed
- Open-Label Safety Study of AXS-05 in Subjects With Depression — Completed